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Letter to the Editor 
Diagnostic Genetics 
First Korean Case of SATB2-Associated 2q32-q33 
Microdeletion Syndrome 
Nae Yu, M.D., Saeam Shin, M.D., and Kyung-A Lee, M.D.
Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea
Chromosome 2q32-q33 deletion syndrome (Online Mendelian 
Inheritance in Man [OMIM]*612313) is a chromosomal disor-
der that was recently characterized by chromosomal microarray 
(CMA) analysis [1, 2]. We present the first Korean case of 2q32-
q33 microdeletion syndrome, which was diagnosed by CMA 
and multiplex ligation probe amplification (MLPA).
 The patient was an 8-yr-old boy, the first child of Korean par-
ents with no relevant family history. He was delivered via cesar-
ean section at full term (39 weeks’ gestation) with a birth weight 
of 1.9 kg (<3rd percentile) and was admitted to the neonatal in-
tensive care unit for one month. Standard karyotyping using pe-
ripheral blood showed no abnormalities, and his brain ultrasono-
gram was normal. He had hypospadias and undescended testi-
cles at birth and underwent surgical repair (urethroplasty and bi-
lateralorchiopexy) at 15 months. Delayed motor development 
was apparent at 6 months, and he could not walk until 32 
months. Developmental evaluation at the age of 4 yr using the 
Denver developmental screening test revealed a motor delay of 
16 months and social cognitive delay. Delayed acquisition of lan-
guage skills, mental retardation, and central hypotonia were also 
established at that time. The patient had visited the emergency 
department intermittently because of recurrent non-febrile sei-
zure (generalized tonic clonic). He had also been to a dentist to 
address crowded teeth and dental caries. 
 At the age of 8 yr and 4 months, the patient was admitted 
again for seizure. Brain magnetic resonance imaging yielded 
normal findings. On physical examination, body weight of 18.4 
kg (<3rd percentile), height of 124.8 cm (25th-50th percentile), 
head circumference of 50 cm (3rd percentile), and craniofacial 
dysmorphic features, including microcephaly and crowded 
teeth, were found. Written informed consent for genetic analysis 
was obtained from the parents according to the ethical guidance 
of the institutional review board. CMA (Cytoscan 750K array; Af-
fymetrix, Santa Clara, CA, USA) analysis revealed a 7.5-Mb inter-
stitial deletion on 2q32.3-33.1, which contained 28 genes: arr 
2q32.3q33.1(194,402,946-201,865,887) ×1 (SLC39A10, 
DNAH7, STK17B, GTF3C3, PGAP1, ANKRD44, SF3B1, HSPD1, 
MOB4, RFTN2, HSPE1, MARS2, BOLL, PLCL1, SATB2, 
FTCDNL1, TYW5, SPATS2L, KCTD17, SGOL2, AOX1, NIF3L1, 
BZW1, CLK1, PPIL3, NIF3L1, ORC2, FAM126B) (Fig. 1A). 
SATB2 deletion on 2q33.1 was confirmed (rsa 2q33.1×1) (Fig. 
1B) by MLPA using the MLPA P245 kit (MRC-Holland, Amster-
dam, Netherlands). 
 SATB2 gene (OMIM*608148), a critical region in 2q32-q33 
microdeletion syndrome, specifically binds to the nuclear matrix 
attachment regions involved in transcriptional regulation and 
chromatin remodeling and shows remarkable evolutionary con-
servation [3]. SATB2 gene regulates craniofacial development 
and cortical neuron differentiation. Thus, SATB2 gene acts as a 
molecular node in the transcriptional network regulating skeletal 
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development and osteoblast differentiation [4]. SATB2 haploin-
sufficiency is considered a cause of craniofacial dysmorphism 
(including cleft palate), mental retardation, and autism spectrum 
disorders associated with deletions and translocations at 2q32-
q33 [5]. Recently, a novel clinical entity termed SATB2-associ-
ated syndrome, characterized by severe intellectual disability, 
speech delay, cleft or high-arched palate, and abnormal denti-
tion (crowded and irregularlyshaped teeth), was proposed [3]. 
The current patient fit that clinical and molecular profile with the 
exception of a cleft palate. Genetic analysis with CMA, a first-tier 
screening tool for unexplained developmental delay in many 
other countries [6, 7], is essential in the diagnosis and clear de-
Fig. 1. Chromosomal microarray profile of chromosome 2. (A) The whole chromosome 2 view shows copy number loss in the 2q32.3-33.1 
region. Blue dots with a log2 value of -1 represent a 1:2 copy number ratio of the test to reference genomic DNA, indicating a heterozygous 
deletion (arrow). The expansion view of the 2q32-33 region revealed a 7.5-Mb heterozygous interstitial deletion in chr2:194,402,946-
201,865,887 (including SATB2 gene). Bars represent the deletion sizes in the current case and other 2q32-q33 microdeletion syndrome 
cases. (B) MLPA analysis (red: control, blue: patient) results show heterozygous deletion of SATB2 gene on 2q33.1 (arrows), rsa 2q33.1×1.
Abbreviation: MLPA, Mutiplex ligation-dependent probe amplification. 
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Table 1. Comparison of the present patient with other reported patients with 2q32-q33 microdeletion syndrome or translocation involving 
2q32
Characteristic Present patient
Balasubramanian 
et al. (2011) [1]
Balasubramanian 
et al. (2011) [1]
Balasubramanian 
et al. (2011) [1]
Balasubramanian 
et al. (2011) [1]
Rosenfeld et al. 
(2009) [2]
de Ravel et al. 
(2009) [9]
Age/sex 8.3 yr/M 8.5 yr/M 8 yr/F 11 yr/M <1 yr/M 21 yr/M 20 yr/M
Deletion range* 2q32.3q33.1 
   (7.5 Mb)
2q32.3q33.1 
   (5.9 Mb)
Breakpoint: 2q32 2q31q33.3 
   (8.1 Mb*)
Breakpoint: 
   SATB2 gene
2q33.1 
   (0.17 Mb, SATB2)
2q32.3q33.2 
   (14.18 Mb*)
Birth weight† 1.9 kg (<3rd) 2.5 kg (<25th) <10th 2.5 kg (<25th) 3.2 kg (50th) 50th 2.25 kg (<3rd)
Craniofacial 
   features
Microcephaly High forehead Long face, 
   micrognathia
Long and narrow face, 
   micrognathia
Microcephaly, 
   micrognathia
Macrocephaly, 
   micrognathia
Microcephaly, long 
   and narrow face
-Teeth Crowded Crowded ND Short and broad ND Crowded Broad 
-Cleft palate − + + + ND + − (high arched)
Genitalia Hypospadias Hypospadias Normal Small, undescended 
   testes
Normal Small testes Normal
Seizure + (febrile) − − + (febrile) + − −
Developmental 
   delay
Speech delay, 
   hypotonia
No active speech, 
   hypotonia
Mild speech delay No active speech, 
   hypotonia
+ Severe speech 
   delay, hypotonia
Severe speech 
   delay, hypotonia
Mental 
   retardation
+ + ND + (severe) ND + (severe) + (severe) 
Brain MRI/CT Normal ND Normal Enlarged cerebral 
   ventricles,
   cerebellarhypoplasia 
Enlarged cerebral 
   ventricles, 
   agenesis of the 
   corpus callosum
ND Normal
Chromosomal 
   findings
46,XY ND ND ND 46,XX,t(2;11)
   (q33;p14)
46,XY,del(2)
   (q31q33.3)
46,XY,t(2;14)
   (q33;q22)
*The minimal range of deletion is described because the deleted region was confirmed by fluorescent in situ hybridization; †Numbers in parentheses show 
percentile score of birth weight. 
Abbreviations: GTC, generalized tonic clonic; ND, no data applicable; MRI, magnetic resonance imaging; CT, computed tomography.
lineation of 2q32-q33 microdeletion syndrome. Currently, in Ko-
rea, CMA cannot be performed for routine diagnostic purposes 
for a child with developmental delay. Therefore, this patient was 
not properly diagnosed until the age of 8 yr, despite a strong sus-
picion of a genetic basis. 
 To date, less than 30 cases of 2q32-q33 microdeletion syn-
drome involving various sizes of deletions have been reported [1, 
2, 8, 9]. Some of these cases and their characteristics are sum-
marized in Table 1. Craniofacial dysmorphism, developmental 
delay, and mental retardation were commonly present, and hypo-
spadias occurred in only one patient [1]. The deleted region in 
the patient with hypospadias (chr2: 194,947,694-200,850,112) 
was also entirely deleted in the present patient (Fig. 1A). The 
phenotypic differences seen in these two patients were seizure 
(seen only in our patient) and cleft palate (seen only in the other 
patient). This implies that genes other than SATB2 are involved 
in the development of cleft palate, and that the distal 1-Mb re-
gion of the deletion end in this patient (chr2: 200,850,112-
201,865,887) might include the genetic cause of recurrent sei-
zures. Although many genes have been suggested as the ge-
netic cause of hypospadias [10], the deleted genes the above 
two cases have in common could also be candidate genes for 
hypospadias. Given the variability in the observed phenotype, 
additional case studies are needed to elucidate the role of each 
of those genes.
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